Sponsor content
330 result(s) found, displaying 151 to 160
-
Australian public assessment report (AusPar)New AusPAR for Vaxzevria (ChAdOx-1-S) for the prevention of COVID-19 caused by SARS-CoV-2
-
Prescription medicine decision summaryTGA decision: Koselugo (selumetinib) is approved to treat paediatric patients aged 2 years and above, with neurofibromatosis type 1 (NF1)
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FASENRA PEN benralizumab 30 mg in 1 mL solution for injection prefilled pen.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CALQUENCE acalabrutinib 100 mg capsule blister pack.
-
Designation or determinationProvisional determination
-
Australian public assessment report (AusPar)Australian Public Assessment Report for ChAdOx1-S - COVID-19 Vaccine AstraZeneca
-
-
Designation or determinationPriority review
-
Prescription medicine registrationActive ingredients: trastuzumab deruxtecan.